Department of Cardiovascular, Xiangya Hospital of Central South University, Changsha, China.
Clin Exp Hypertens. 2022 Jan 2;44(1):20-25. doi: 10.1080/10641963.2021.1969663. Epub 2021 Sep 15.
Primary hypertension is one of the most well-known risk factors for cardiovascular disease. Currently, there is still no ideal indicator for left ventricular end-diastolic pressure.
73 hypertension patients and 37 healthy people were enrolled in this study. Each member was examined with conventional echocardiography including multiple indicators such as Peak mitral valve flow velocity (E, A), E/A, left atrial volume index (LAVl), tissue Doppler (PW-TDI) peak velocities during early and late diastolic mitral valve flow (e '), E/e ', and GLS. We have collected clinical data from all enrolled members. The above cardiac ultrasound indicators were obtained before the antihypertensive treatment, one month and three months after treatment.
Left ventricular end-diastolic pressure (LVEDP) was positively correlated and negatively correlated with GLS (r = 0.638, < .01) and E/e' (r = -0.578, < .05), respectively. The hypertensives had lower e' value and higher values of GLS, E/e', and LAVI than the control group ( < .05). GLS and E/e' were significantly lower in hypertension group than those in the Control group after one month and three months of treatment ( < .05). The improvement rate of GLS was significantly higher than those in the improvement rate of e', E/e', LAVI after treatment ( < .05).
The GLS improvement rate was significantly higher than those of e', E/e' after one and three-month treatment. Therefore, GLS might be a potential ideal index for patients with anti-hypertension treatment. The results obtained in this study provide useful information for further study.
原发性高血压是心血管疾病最著名的危险因素之一。目前,仍然没有理想的左心室舒张末期压力指标。
本研究纳入了 73 例高血压患者和 37 名健康人。对所有成员进行了常规超声心动图检查,包括多个指标,如峰值二尖瓣血流速度(E、A)、E/A、左心房容积指数(LAVl)、组织多普勒(PW-TDI)舒张早期和晚期二尖瓣血流峰值速度(e')、E/e'和 GLS。我们从所有入组成员中收集了临床数据。上述心脏超声指标在降压治疗前、治疗后 1 个月和 3 个月时获得。
左心室舒张末期压力(LVEDP)与 GLS 呈正相关(r = 0.638,< 0.01),与 E/e'呈负相关(r = -0.578,< 0.05)。与对照组相比,高血压组的 e'值较低,GLS、E/e'和 LAVI 值较高(< 0.05)。与对照组相比,高血压组治疗 1 个月和 3 个月后 GLS 和 E/e'明显降低(< 0.05)。治疗后 GLS 的改善率明显高于 e'、E/e'、LAVI 的改善率(< 0.05)。
治疗 1 个月和 3 个月后,GLS 的改善率明显高于 e'、E/e'。因此,GLS 可能是抗高血压治疗患者的一个潜在理想指标。本研究结果为进一步研究提供了有用的信息。